dr_benedetta_montagnini_0

Dr Benedetta Montagnini

pharmafile | June 30, 2022 | Appointment | |   

Metrion Biosciences has announced the appointment of Dr Benedetta Montagnini as Head of European Business Development. The appointment follows the recent creation of a Client Services team, as Metrion expands its operations and enhanced drug discovery capabilities internationally.

Dr Benedetta Montagnini, Head of European Business Development at Metrion Biosciences, shared: “I am delighted to be joining the team at this point in its expansion. I look forward to working with both existing and new clients, and supporting the community across Europe. I have a great respect for Metrion’s strong scientific focus for ion channel drug discovery, and vision for the future development of its services.”

Metrion is a specialist ion channel contract research and drug discovery company. Dr Montagnini has over 20 years’ experience working within the drug discovery services environment.

 

Related Content

No items found

Latest content